Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Septa Pharmaceuticals is a Canadian specialty pharmaceutical company and contract development and manufacturing organization (CDMO) based in Mississauga, Ontario. The company provides integrated services including formulation development, analytical R&D, and commercial-scale manufacturing of generic drug products. Their expertise covers a wide range of dosage forms, including solid orals, liquids, semi-solids, and powders. Septa operates a state-of-the-art facility that is licensed by Health Canada and compliant with FDA standards, serving both domestic and international markets. In addition to contract services, the firm develops and markets its own portfolio of generic medications focused on high-demand therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Septa Pharmaceuticals.